Protein ID Gene Symbol Unique + Razor Sequence Coverage

Protein ID Gene Symbol Unique + Razor Sequence Coverage

Dengjel et al. Mol. BioSyst., 2010, Supplementary Material (ESI) for Molecular BioSystems DOI: 10.1039/c003962d This journal is (c) The Royal Society of Chemistry, 2010 Supplementary Table 1: Fibroblast control. Cell lysates were prepared from unlabled (Arg0/Lys0) and labled (Arg10/Lys8 fibroblasts after 14 cell doublings in culture (D14). Shown are normalized log2 transformed protein ratios of identified protein identification a minimum of 2 peptides per protein has to be identified (unique + razor). The database used for identification decoy database based on IPI v. 3.59 containing in total 160,820 entries. As a criterium for identification the posterior errror probaility rate of identified proteins (PEP) is shown. The peptide numbers represent peptides used for quantitation. Unique + Razor Sequence Peptide Variability Protein ID Gene Symbol Coverage [%] PEP Log2 Ratio No. [%] Quantil IPI00021033; COL3A1 11.1 5.91E‐62 ‐4.651 4 165.2 Q1 IPI00761105; TADA2B 1.7 2.46E‐02 ‐4.494 2 57.9 Q1 IPI00152007 ARHGEF17 2.3 5.41E‐09 ‐3.687 2 92.5 Q1 IPI00300725;C KRT6A 27 6.82E‐61 ‐3.299 4 204.0 Q1 IPI00022229; APOB 0.7 5.68E‐29 ‐2.944 8 202.2 Q1 IPI00298860; LTF 51 8.02E‐197 ‐2.834 13 105.6 Q1 IPI00384444; KRT14 36.4 6.18E‐85 ‐2.542 13 143.3 Q1 IPI00305461; ITIH2 5 2.86E‐09 ‐1.174 3 367.3 Q1 IPI00420088; KIAA0174 7.5 9.34E‐03 ‐0.892 2 62.3 Q1 IPI00012887; CTSL1 12 3.13E‐21 ‐0.618 3 47.8 Q1 IPI00375714; HSPB7 17.1 1.31E‐05 ‐0.615 2 69.5 Q1 IPI00384140 ESR2 10.6 4.35E‐04 ‐0.551 3 8.6 Q1 IPI00300599; CTSK 46.5 <1.0E‐304 ‐0.515 9 11.7 Q1 IPI00167949; MX1 18.3 7.22E‐90 ‐0.508 8 13.1 Q1 IPI00848334; KIF2A 8.5 3.58E‐39 ‐0.467 2 33.7 Q2 IPI00296534; FBLN1 18.2 2.50E‐34 ‐0.462 4 25.3 Q2 IPI00296713; GRN 3.9 1.10E‐14 ‐0.455 2 9.9 Q2 IPI00297646;C COL1A1 46.7 <1.0E‐304 ‐0.419 58 49.1 Q2 IPI00749429; TTYH3 2.7 8.52E‐48 ‐0.406 2 8.3 Q2 IPI00026111; TMCO1 12.2 1.52E‐38 ‐0.389 2 20.8 Q2 IPI00027780; MMP2 17.7 7.88E‐76 ‐0.383 8 12.4 Q2 IPI00384280; PCYOX1 35.4 1.98E‐191 ‐0.377 8 18.9 Q2 IPI00873137; COL1A2 36.9 <1.0E‐304 ‐0.370 38 24.9 Q2 IPI00100199; CYBRD1 7.7 3.13E‐15 ‐0.361 3 14.0 Q2 Page 1 Dengjel et al. Mol. BioSyst., 2010, Supplementary Material (ESI) for Molecular BioSystems DOI: 10.1039/c003962d This journal is (c) The Royal Society of Chemistry, 2010 IPI00455473; MIA3 5.6 3.30E‐69 ‐0.360 2 15.0 Q2 IPI00032292; TIMP1 24.6 9.12E‐26 ‐0.321 4 17.2 Q2 IPI00871585; BID 11.1 8.30E‐51 ‐0.321 3 15.3 Q2 IPI00394994; C14orf49 4 4.51E‐22 ‐0.320 2 20.3 Q2 IPI00024775; RAB7L1 10.8 1.55E‐19 ‐0.320 2 35.1 Q2 IPI00016621; AP2A2 25 <1.0E‐304 ‐0.313 7 48.8 Q2 IPI00005573; NT5C 18.9 3.08E‐23 ‐0.305 2 15.6 Q2 IPI00783109; MTSS1L 7.2 3.32E‐10 ‐0.296 2 3.0 Q2 IPI00913924; LRRC15 25.9 7.68E‐125 ‐0.286 8 7.0 Q2 IPI00477611; COL5A1 4.9 7.86E‐32 ‐0.278 5 14.0 Q2 IPI00002606; SCIN 7.1 3.37E‐12 ‐0.278 3 2.5 Q2 IPI00329719; MYO1D 54.9 <1.0E‐304 ‐0.266 37 11.8 Q2 IPI00024642; CCDC47 15.7 2.45E‐34 ‐0.265 2 0.5 Q2 IPI00639812; MGST3 16.9 1.83E‐97 ‐0.262 2 1.9 Q2 IPI00103467; ALDH1B1 23.8 6.40E‐265 ‐0.262 3 6.2 Q2 IPI00304577; AP2A1 48.8 <1.0E‐304 ‐0.262 34 34.0 Q2 IPI00171412; SUMF2 22.5 6.80E‐82 ‐0.261 4 9.0 Q2 IPI00007675; DYNC1LI1 14.3 9.42E‐74 ‐0.260 3 21.1 Q2 IPI00643567 CAP1 18.2 <1.0E‐304 ‐0.260 3 15.3 Q2 IPI00640525; PPGB 19.1 1.54E‐91 ‐0.256 4 7.4 Q2 IPI00303602; AIDA 11.4 5.65E‐10 ‐0.252 2 18.1 Q2 IPI00900260; ARHGEF7 12 1.95E1.95E‐91 ‐00.252.252 2 18.218.2 Q2 IPI00247063; MME 54.7 <1.0E‐304 ‐0.248 33 8.9 Q2 IPI00018953; DPP4 41.9 <1.0E‐304 ‐0.247 28 16.6 Q2 IPI00152695; WDR82 17.3 1.06E‐41 ‐0.245 2 20.5 Q2 IPI00303195; SYNC 6.8 1.31E‐25 ‐0.244 2 37.0 Q2 IPI00291136 COL6A1 40.1 <1.0E‐304 ‐0.238 28 6.3 Q2 IPI00908768; HSPB6 43.9 1.67E‐76 ‐0.238 3 5.5 Q2 IPI00009896; EPHX1 28.6 5.26E‐56 ‐0.236 8 14.9 Q2 IPI00000230; DKFZp586K2222 48.9 3.25E‐272 ‐0.236 11 17.6 Q2 IPI00182728; VPS4B 16 1.67E‐47 ‐0.234 3 15.2 Q2 IPI00465428; VPS13C 4.6 7.09E‐49 ‐0.234 8 8.4 Q2 IPI00887461; HLA‐B 29.3 3.54E‐170 ‐0.232 6 7.1 Q2 Page 2 Dengjel et al. Mol. BioSyst., 2010, Supplementary Material (ESI) for Molecular BioSystems DOI: 10.1039/c003962d This journal is (c) The Royal Society of Chemistry, 2010 IPI00003766 ETHE1 36.2 2.02E‐67 ‐0.231 4 19.3 Q2 IPI00292894 TSR1 3.6 1.16E‐03 ‐0.230 2 40.6 Q2 IPI00295595; CERCAM 7.1 3.24E‐28 ‐0.229 2 1.8 Q2 IPI00028564; GBP1 23.1 9.18E‐48 ‐0.229 9 24.0 Q2 IPI00018352; UCHL1 53.8 4.30E‐202 ‐0.229 19 4.3 Q2 IPI00288947; GNAQ 19.2 1.05E‐82 ‐0.225 2 0.5 Q2 IPI00021057; SLC12A4 7.9 8.01E‐12 ‐0.225 5 26.9 Q2 IPI00095891; GNAS 8.5 3.95E‐32 ‐0.223 3 5.2 Q2 IPI00790064; NDUFB9 19 4.45E‐53 ‐0.219 2 23.0 Q2 IPI00796919; GLB1 22.5 3.73E‐190 ‐0.217 6 8.6 Q2 IPI00012119; DCN 21.4 1.22E‐40 ‐0.214 3 8.2 Q2 IPI00295741; CTSB 46.9 <1.0E‐304 ‐0.213 17 19.4 Q2 IPI00028565; GBP2 6.9 1.45E‐09 ‐0.210 2 3.5 Q2 IPI00296485 MAP1S 5.6 1.31E‐17 ‐0.208 2 21.0 Q2 IPI00014572 SPARC 26.1 9.58E‐69 ‐0.207 5 42.2 Q2 IPI00031479; PDIA5 14.1 2.50E‐18 ‐0.206 3 11.3 Q2 IPI00156689; VAT1 61.3 <1.0E‐304 ‐0.205 32 7.9 Q2 IPI00220278; MYL9 46.5 <1.0E‐304 ‐0.202 5 3.3 Q2 IPI00745313; AEBP1 9.3 2.77E‐63 ‐0.200 6 4.0 Q2 IPI00016373; RAB13 21.2 1.21E‐35 ‐0.200 2 1.9 Q2 IPI00014533; UBTF 8 6.16E‐19 ‐0.200 3 17.4 Q2 IPI00290279; ADK 27.127.1 6.67E6.67E‐75 ‐00.200.200 5 19.819.8 Q2 IPI00002824; CSRP2 61.7 7.58E‐69 ‐0.200 6 4.4 Q2 IPI00554521; FTH1 44.3 3.51E‐51 ‐0.198 7 40.0 Q2 IPI00029111; LCRMP 44 <1.0E‐304 ‐0.198 11 9.8 Q2 IPI00299066; LPXN 22 2.03E‐151 ‐0.193 3 0.5 Q2 IPI00009946; TOMM34 18.8 6.18E‐17 ‐0.192 3 18.7 Q2 IPI00797603; PRPSAP1 15.1 6.69E‐37 ‐0.192 3 21.6 Q2 IPI00011229; CTSD 48.3 <1.0E‐304 ‐0.192 33 15.3 Q2 IPI00022200; COL6A3 54.5 <1.0E‐304 ‐0.191 355 18.9 Q2 IPI00293088; GAA 24.5 <1.0E‐304 ‐0.190 4 22.2 Q2 IPI00009236; CAV1 50 6.46E‐153 ‐0.190 19 6.3 Q2 IPI00291238; FBLIM1 22.3 6.70E‐51 ‐0.190 3 10.5 Q2 Page 3 Dengjel et al. Mol. BioSyst., 2010, Supplementary Material (ESI) for Molecular BioSystems DOI: 10.1039/c003962d This journal is (c) The Royal Society of Chemistry, 2010 IPI00375631 ISG15 13.3 1.45E‐05 ‐0.187 2 33.3 Q2 IPI00058192; POFUT1 9.3 7.10E‐38 ‐0.186 3 11.4 Q2 IPI00873226; hTGP 1.3 2.86E‐03 ‐0.186 2 14.5 Q2 IPI00375676; FTL 35.6 1.27E‐122 ‐0.186 5 9.4 Q2 IPI00011932 HSPA12A 9.5 2.46E‐30 ‐0.184 2 1.2 Q2 IPI00022745; MVD 8.5 2.11E‐34 ‐0.183 2 23.4 Q2 IPI00018769; THBS2 10.4 1.34E‐122 ‐0.183 7 10.6 Q2 IPI00298111; SNX6 31.1 6.07E‐81 ‐0.182 6 15.4 Q2 IPI00328113; FBN1 2 1.00E‐21 ‐0.179 3 36.3 Q2 IPI00470529; GPNMB 5.8 9.65E‐109 ‐0.179 14 11.4 Q2 IPI00026314; GSN 51.3 <1.0E‐304 ‐0.178 42 9.2 Q2 IPI00166955; CNPY4 6.2 3.49E‐97 ‐0.177 2 2.7 Q2 IPI00871680; ARFGAP2 14 1.55E‐136 ‐0.177 2 18.9 Q2 IPI00332106; PBXIP1 21.9 1.86E‐146 ‐0.177 6 8.5 Q2 IPI00743696; COL4A1 4 1.82E‐08 ‐0.177 2 13.1 Q2 IPI00021264 CNN1 42.4 1.67E‐126 ‐0.177 4 3.9 Q2 IPI00856045; AHNAK2 41.1 <1.0E‐304 ‐0.177 107 15.0 Q2 IPI00023510; RAB5A 35.3 1.11E‐94 ‐0.177 8 14.5 Q2 IPI00056334; PRKCDBP 50.2 7.35E‐130 ‐0.177 9 9.6 Q2 IPI00025318; SH3BGRL 56.1 5.58E‐74 ‐0.176 5 7.9 Q2 IPI00296157; RETSAT 8.2 1.73E‐26 ‐0.176 2 8.8 Q2 IPI00884192; GPX4 33.833.8 9.09E9.09E‐63 ‐00.173.173 4 4.54.5 Q2 IPI00028122; PSIP1 8.7 9.10E‐63 ‐0.173 4 12.7 Q2 IPI00060627 CCDC124 25.1 1.83E‐09 ‐0.173 2 1.3 Q2 IPI00385495; LMF2 11.2 1.33E‐72 ‐0.172 8 20.1 Q2 IPI00100673; VPS24 20.3 2.34E‐07 ‐0.171 2 1.9 Q2 IPI00004312; STAT2 29.5 3.44E‐227 ‐0.171 22 23.9 Q2 IPI00168878 TOR1AIP2 9.8 6.53E‐23 ‐0.171 3 3.7 Q2 IPI00797038; PCK2 31.2 3.47E‐231 ‐0.170 9 9.5 Q2 IPI00018248; KDELR2 8 9.59E‐36 ‐0.170 6 12.2 Q2 IPI00329696; FAM82B 24.2 3.48E‐23 ‐0.170 4 20.4 Q2 IPI00007084 SLC25A13 23.1 6.33E‐230 ‐0.170 5 13.4 Q2 IPI00003128; P4HA2 45.6 <1.0E‐304 ‐0.169 4 2.1 Q2 Page 4 Dengjel et al.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    426 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us